← Back to Search

Legume

Split yellow pea soup for Blood Sugar (PEA4 Trial)

N/A
Waitlist Available
Led By Heather Blewett, PhD
Research Sponsored by St. Boniface Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 120 min
Awards & highlights

PEA4 Trial Summary

This trial is testing different kinds of peas to see which one has the biggest effect on blood sugar levels in healthy people.

Who is the study for?
This trial is for generally healthy men and women aged 18-40, with a BMI of 18.5-30. They should regularly eat three meals a day and be willing to follow the study's requirements after giving informed consent.Check my eligibility
What is being tested?
The study is testing how different types of soup—split yellow pea soup, whole yellow pea soup, and potato soup—affect blood sugar control in healthy individuals.See study design
What are the potential side effects?
Since the interventions are food-based (different types of soups), side effects may be minimal but could include digestive discomfort or allergic reactions if participants have sensitivities to ingredients.

PEA4 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 min
This trial's timeline: 3 weeks for screening, Varies for treatment, and 120 min for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-prandial glucose
Post-prandial insulin
Secondary outcome measures
Desire to eat
Fullness
Hunger
+1 more
Other outcome measures
Acceptability of soup aroma
Acceptability of soup color
Acceptability of soup flavor
+3 more

PEA4 Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Whole yellow peaExperimental Treatment1 Intervention
Soup containing 25g available carbohydrates from whole yellow peas. Intervention: Whole yellow pea soup
Group II: Split yellow peaExperimental Treatment1 Intervention
Soup containing 25g available carbohydrates from split yellow peas. Intervention: Split yellow pea soup
Group III: PotatoPlacebo Group1 Intervention
Soup containing 25g available carbohydrates from potatoes. Intervention: Potato soup

Find a Location

Who is running the clinical trial?

Agriculture and Agri-Food CanadaOTHER_GOV
33 Previous Clinical Trials
2,281 Total Patients Enrolled
St. Boniface HospitalLead Sponsor
51 Previous Clinical Trials
11,585 Total Patients Enrolled
University of ManitobaOTHER
595 Previous Clinical Trials
199,498 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the central aim of this investigation?

"This study's main assessment parameter, measured over a two-hour span of time, will be Post-prandial insulin levels. Additionally, Desire to Eat (AUC with Visual Analog Scales), Fullness (AUC with Visual Analog Scales) and Hunger (AUC with Visual Analog Scales) are all secondary endpoints that will also be monitored in the trial."

Answered by AI

Is there still participation availability for this experiment?

"According to clinicaltrials.gov, this trial is not currently recruiting patients for participation. The study dates back to November 8th 2017 and was last amended on October 24th 2022. Nonetheless, 1 alternative medical trial is taking in participants at the moment."

Answered by AI

Am I eligible to participate in this experiment?

"This clinical trial is seeking 24 individuals aged 18-40 with postprandial glycemia. To qualify, these participants must be habitually consuming breakfast in the morning, lunch at mid-day, and dinner in the evening; have a BMI between 18.5 to 30.0 kg/m2; demonstrate general healthiness; provide informed consent for their participation and comply with all study requirements."

Answered by AI

Does this clinical research include participants who are at least 18 years old?

"Eligibility for this clinical trial necessitates participants to be of age 18 or older, but no more than 40."

Answered by AI
~3 spots leftby Apr 2025